Mubadala Investment Company’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$63.4M Hold
2025
Q2
$65.7M Hold
2025
Q1
$68.7M Hold
2024
Q4
$87.8M Hold
2024
Q3
$85.6M Hold
2024
Q2
$97.4M Hold
2024
Q1
$129M Hold
2023
Q4
$128M Buy